21
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of COPD (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on pathophysiological processes underlying Chronic Obstructive Pulmonary Disease (COPD) interventions, patient focused education, and self-management protocols. Sign up for email alerts here.

      39,063 Monthly downloads/views I 2.893 Impact Factor I 5.2 CiteScore I 1.16 Source Normalized Impact per Paper (SNIP) I 0.804 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Information Needs in COPD After an Educational Programme: Influence in Exacerbations and Admissions

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Improving patients’ information needs (IN) may contribute to better control in COPD. This study analyses IN using Lung Information Needs Questionnaire (LINQ) following an educational intervention, evaluates how clinical characteristics modify IN, and studies high IN as a prognostic factor for COPD exacerbations and hospital admissions.

          Methods

          Cohort of 143 patients with initial diagnosis of COPD included in a structured educational program. Two months after completing the program, IN was assessed using LINQ. Correlations between IN and clinical variables of COPD and distribution of IN in different clinical groups were analyzed. Univariate and multivariate analysis was performed to determine influence of IN on exacerbations and COPD admissions over the following year.

          Results

          LINQ scored 6.3±2.9. There were no differences in LINQ scoring between different clinical groups, but LINQ score positively correlated with age (r=0.184, p=0.029). High IN was a predictor of COPD hospitalizations (HR 2.3 [95% CI 1.1–5.1] (p=0.029)) but not of less severe exacerbations (p=0.334).

          Conclusion

          IN was not associated with any clinical variables, but it correlated with age. High IN proved to be an independent predictor of admissions.

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

          The Lancet, 349(9064), 1498-1504
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

            The objective of this study was to develop a prospectively applicable method for classifying comorbid conditions which might alter the risk of mortality for use in longitudinal studies. A weighted index that takes into account the number and the seriousness of comorbid disease was developed in a cohort of 559 medical patients. The 1-yr mortality rates for the different scores were: "0", 12% (181); "1-2", 26% (225); "3-4", 52% (71); and "greater than or equal to 5", 85% (82). The index was tested for its ability to predict risk of death from comorbid disease in the second cohort of 685 patients during a 10-yr follow-up. The percent of patients who died of comorbid disease for the different scores were: "0", 8% (588); "1", 25% (54); "2", 48% (25); "greater than or equal to 3", 59% (18). With each increased level of the comorbidity index, there were stepwise increases in the cumulative mortality attributable to comorbid disease (log rank chi 2 = 165; p less than 0.0001). In this longer follow-up, age was also a predictor of mortality (p less than 0.001). The new index performed similarly to a previous system devised by Kaplan and Feinstein. The method of classifying comorbidity provides a simple, readily applicable and valid method of estimating risk of death from comorbid disease for use in longitudinal studies. Further work in larger populations is still required to refine the approach because the number of patients with any given condition in this study was relatively small.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

              American Journal of Respiratory and Critical Care Medicine, 195(5), 557-582
                Bookmark

                Author and article information

                Journal
                Int J Chron Obstruct Pulmon Dis
                Int J Chron Obstruct Pulmon Dis
                copd
                copd
                International Journal of Chronic Obstructive Pulmonary Disease
                Dove
                1176-9106
                1178-2005
                27 October 2020
                2020
                : 15
                : 2663-2671
                Affiliations
                [1 ]Hospital Universitario Marqués de Valdecilla, Servicio de Neumología, Universidad de Cantabria , Santander, Spain
                [2 ]Universidad de Cantabria , Santander, Spain
                [3 ]Hospital Universitario Marqués de Valdecilla, Servicio de Neumología , Santander, Spain
                [4 ]Servicio Cántabro de Salud , Santander, Spain
                [5 ]Hospital Universitario Lucus Augusti, Servicio de Neumología, Grupo C039 Biodiscovery HULA-USC, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) , Santander, Spain
                Author notes
                Correspondence: Carlos Antonio Amado Servicio de Neumología, Hospital Universitario Marqués de Valdecilla , Avenida Valdecilla SN, Santander39001, Cantabria, Spain Email carlosantonio.amado@scsalud.es
                Author information
                http://orcid.org/0000-0002-5598-1753
                http://orcid.org/0000-0002-1328-9136
                http://orcid.org/0000-0002-1387-2655
                http://orcid.org/0000-0002-3759-5322
                Article
                275002
                10.2147/COPD.S275002
                7603652
                33149564
                f3d572d1-4cbf-4914-9d61-72ba7b574aaa
                © 2020 Amado et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 11 August 2020
                : 25 September 2020
                Page count
                Figures: 6, Tables: 15, References: 25, Pages: 9
                Categories
                Original Research

                Respiratory medicine
                copd,education,copd exacerbation
                Respiratory medicine
                copd, education, copd exacerbation

                Comments

                Comment on this article